Caffeine Acetylsalicylic Acid Butalbital (Pronal) shortage status
Widespread shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Caffeine Acetylsalicylic Acid Butalbital is in a widespread shortage in Canada. 2 of 3 reported products are affected. The latest manufacturer estimate for full recovery is Oct 20, 2026.
A combination pain reliever containing caffeine, ASA and a barbiturate, used for tension headaches.
Products affected
2 / 3
In shortage since
Sep 4, 2024
Est. full return
Oct 20, 2026
Reports on file
15
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
TEVA-TECNAL
40MG
330MG
50MG · TABLET · TEVA CANADA LIMITED
DIN 00608211 · since Feb 4, 2026, est. end Oct 20, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-TECNAL
330MG
40MG
50MG · CAPSULE · TEVA CANADA LIMITED
DIN 00608238 · since Sep 4, 2024, est. end Jun 20, 2026 · Disruption of the manufacture of the drug.
Discontinued
TEVA-TECNAL
330MG
40MG
50MG · CAPSULE · TEVA CANADA LIMITED
DIN 00608238
Discontinued
TEVA-TECNAL
50MG
330MG
40MG · TABLET · TEVA CANADA LIMITED
DIN 00608211
Resolved
TEVA-TECNAL
330MG
40MG
50MG · CAPSULE · TEVA CANADA LIMITED
DIN 00608238 · ended Jun 10, 2024 · Disruption of the manufacture of the drug.
Resolved
TEVA-TECNAL
330MG
40MG
50MG · TABLET · TEVA CANADA LIMITED
DIN 00608211 · ended Jan 18, 2024 · Disruption of the manufacture of the drug.
Resolved
TEVA-TECNAL
330MG
40MG
50MG · TABLET · TEVA CANADA LIMITED
DIN 00608211 · ended Jul 5, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-TECNAL
330MG
40MG
50MG · CAPSULE · TEVA CANADA LIMITED
DIN 00608238 · ended Oct 17, 2022 · Disruption of the manufacture of the drug.
Resolved
TEVA-TECNAL
330MG
40MG
50MG · CAPSULE · TEVA CANADA LIMITED
DIN 00608238 · ended Jun 30, 2022 · Disruption of the manufacture of the drug.
Resolved
TEVA-TECNAL
50MG
40MG
330MG · TABLET · TEVA CANADA LIMITED
DIN 00608211 · ended Sep 23, 2020 · Disruption of the manufacture of the drug.
Resolved
TEVA-TECNAL
330MG
50MG
40MG · CAPSULE · TEVA CANADA LIMITED
DIN 00608238 · ended Jul 1, 2020 · Disruption of the manufacture of the drug.
Resolved
TEVA-TECNAL
330MG
50MG
40MG · TABLET · TEVA CANADA LIMITED
DIN 00608211 · ended Jun 30, 2019 · Disruption of the manufacture of the drug.
Showing 12 of 15 reports. All reports are on file with Health Canada.
What's happening
Caffeine Acetylsalicylic Acid Butalbital is currently affected by 2 active shortage reports filed with Health Canada by TEVA CANADA LIMITED.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Caffeine Acetylsalicylic Acid Butalbital is classified under “OTHER ANALGESICS AND ANTIPYRETICS” (ATC N02BA).
Recent changes
No changes recorded yet.
Common questions
What is Caffeine Acetylsalicylic Acid Butalbital used for?
A combination pain reliever containing caffeine, ASA and a barbiturate, used for tension headaches.
When will Caffeine Acetylsalicylic Acid Butalbital be back in stock in Canada?
The latest manufacturer estimate is Oct 20, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Caffeine Acetylsalicylic Acid Butalbital in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.